BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to Balance Sheet
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Total Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹162 Cr | ₹192 Cr | ₹84 Cr | ₹113 Cr | ₹115 Cr |
What is the latest Total Liabilities ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹162 Cr |
Mar2022 | ₹192 Cr |
Mar2021 | ₹84 Cr |
Mar2020 | ₹113 Cr |
Mar2019 | ₹115 Cr |
How is Total Liabilities of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹162 Cr | -15.50 | |
Mar2022 | ₹192 Cr | 128.51 | |
Mar2021 | ₹84 Cr | -25.65 | |
Mar2020 | ₹113 Cr | -1.84 | |
Mar2019 | ₹115 Cr | - |
Compare Total Liabilities of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹98.3 Cr | -9.7% | -7.7% | -33.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -9.7% |
-7.7% |
-33.9% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses